Frontline Plc (FRO) Stock: Tracking the Weekly Performance

Biotech Stocks to buy

The stock of Frontline Plc (FRO) has seen a 2.12% increase in the past week, with a -4.02% drop in the past month, and a -8.46% decrease in the past quarter. The volatility ratio for the week is 2.53%, and the volatility levels for the past 30 days are at 2.58% for FRO. The simple moving average for the last 20 days is 2.51% for FRO’s stock, with a simple moving average of -2.04% for the last 200 days.

Is It Worth Investing in Frontline Plc (NYSE: FRO) Right Now?

Frontline Plc (NYSE: FRO) has a higher price-to-earnings ratio of 8.68x compared to its average ratio, The 36-month beta value for FRO is at 0.09. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 3 as “hold,” and 1 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for FRO is 143.15M, and currently, shorts hold a 6.05% of that float. The average trading volume for FRO on October 01, 2024 was 1.56M shares.

FRO) stock’s latest price update

Frontline Plc (NYSE: FRO)’s stock price has soared by 1.40 in relation to previous closing price of 22.85. Nevertheless, the company has seen a gain of 2.12% in its stock price over the last five trading days. globenewswire.com reported 2024-09-30 that –Encouraging progression-free survival data in overall population; continued follow-up needed to allow data to mature further, especially in low ctDNA subgroup where events accrue more slowly

Analysts’ Opinion of FRO

Many brokerage firms have already submitted their reports for FRO stocks, with Jefferies repeating the rating for FRO by listing it as a “Buy.” The predicted price for FRO in the upcoming period, according to Jefferies is $30 based on the research report published on March 21, 2024 of the current year 2024.

Deutsche Bank, on the other hand, stated in their research note that they expect to see FRO reach a price target of $26, previously predicting the price at $17. The rating they have provided for FRO stocks is “Buy” according to the report published on January 09th, 2024.

Deutsche Bank gave a rating of “Hold” to FRO, setting the target price at $17 in the report published on August 25th of the previous year.

FRO Trading at -1.06% from the 50-Day Moving Average

After a stumble in the market that brought FRO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.16% of loss for the given period.

Volatility was left at 2.58%, however, over the last 30 days, the volatility rate increased by 2.53%, as shares surge +0.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.24% lower at present.

During the last 5 trading sessions, FRO rose by +2.20%, which changed the moving average for the period of 200-days by +22.70% in comparison to the 20-day moving average, which settled at $22.61. In addition, Frontline Plc saw 15.56% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for FRO

Current profitability levels for the company are sitting at:

  • 0.35 for the present operating margin
  • 0.37 for the gross margin

The net margin for Frontline Plc stands at 0.31. The total capital return value is set at 0.11. Equity return is now at value 25.17, with 10.66 for asset returns.

Based on Frontline Plc (FRO), the company’s capital structure generated 0.61 points at debt to capital in total, while cash flow to debt ratio is standing at 0.15. The debt to equity ratio resting at 1.59. The interest coverage ratio of the stock is 2.88.

Currently, EBITDA for the company is 938.33 million with net debt to EBITDA at 3.72. When we switch over and look at the enterprise to sales, we see a ratio of 4.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.38.

Conclusion

In conclusion, Frontline Plc (FRO) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts